Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evaxion A (EVAX) Intangibles (2020 - 2022)

Evaxion A posted quarterly Intangibles of $87000.0 for Q4 2022, down 6.45% year-on-year from $93000.0 in Q4 2021, and up 2.35% on a QoQ basis from $85000.0 in Q2 2022.

Evaxion A (EVAX) has 3 years of Intangibles data on file, last reported at $87000.0 in Q4 2022.

  • For the quarter ending Q4 2022, Intangibles fell 6.45% year-over-year to $87000.0; the trailing twelve-month figure through Dec 2022 stood at $87000.0 (down 6.45% YoY), and the FY2022 full-year result was $87000.0, down 6.45% from the prior year.
  • Intangibles for Q4 2022 stood at $87000.0, up from $85000.0 in the prior quarter.
  • Across five years, Intangibles topped out at $100000.0 in Q4 2020 and bottomed at $85000.0 in Q2 2022.
  • The 3-year median for Intangibles is $94000.0 (2021), against an average of $93000.0.
  • Peak annual rise in Intangibles reached 5.21% in 2022, while the deepest fall reached 12.37% in 2022.
  • A 3-year view of Intangibles shows it stood at $100000.0 in 2020, then declined by 7.0% to $93000.0 in 2021, then declined by 6.45% to $87000.0 in 2022.
  • The last three Intangibles figures came in at $87000.0 (Q4 2022), $85000.0 (Q2 2022), and $91000.0 (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.41 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 11,640.44
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 418.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.29 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Revolution Medicines 32.39 Bn 32.39 Bn - 55.80 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 87,000.00
Jun 30, 2022 85,000.00
Mar 31, 2022 91,000.00
Dec 31, 2021 93,000.00
Sep 30, 2021 95,000.00
Jun 30, 2021 97,000.00
Mar 31, 2021 96,000.00
Dec 31, 2020 100,000.00